{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T05:39:24Z","timestamp":1760852364102},"reference-count":74,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2009,9,1]],"date-time":"2009-09-01T00:00:00Z","timestamp":1251763200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2009,9]]},"DOI":"10.1016\/j.atherosclerosis.2008.12.010","type":"journal-article","created":{"date-parts":[[2008,12,16]],"date-time":"2008-12-16T13:22:48Z","timestamp":1229433768000},"page":"1-7","source":"Crossref","is-referenced-by-count":8,"title":["Tweaking the gain on platelet regulation: The tachykinin connection"],"prefix":"10.1016","volume":"206","author":[{"given":"Jonathan M.","family":"Gibbins","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2008.12.010_bib1","doi-asserted-by":"crossref","first-page":"3415","DOI":"10.1242\/jcs.01325","article-title":"Adhesion receptor signalling and the regulation of thrombus formation","volume":"117","author":"Gibbins","year":"2004","journal-title":"J Cell Sci"},{"key":"10.1016\/j.atherosclerosis.2008.12.010_bib2","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1111\/j.1538-7836.2005.01428.x","article-title":"Qualitative disorders of platelets and megakaryocytes","volume":"3","author":"Nurden","year":"2005","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.atherosclerosis.2008.12.010_bib3","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.1056\/NEJMra071014","article-title":"Platelet activation and atherothrombosis","volume":"357","author":"Davi","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.atherosclerosis.2008.12.010_bib4","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1161\/01.RES.0000252802.25497.b7","article-title":"Platelets as immune cells\u2014bridging inflammation and cardiovascular disease","volume":"100","author":"von Hundelshausen","year":"2007","journal-title":"Circ Res"},{"key":"10.1016\/j.atherosclerosis.2008.12.010_bib5","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1084\/jem.20012044","article-title":"A critical role of platelet adhesion in the initiation of atherosclerotic lesion formation","volume":"196","author":"Massberg","year":"2002","journal-title":"J Exp Med"},{"key":"10.1016\/j.atherosclerosis.2008.12.010_bib6","doi-asserted-by":"crossref","first-page":"313","DOI":"10.2174\/157016108785909760","article-title":"Resistance to aspirin and thienopyridines in diabetes mellitus and metabolic syndrome","volume":"6","author":"Anfossi","year":"2008","journal-title":"Curr Vasc Pharmacol"},{"key":"10.1016\/j.atherosclerosis.2008.12.010_bib7","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1161\/01.ATV.0000151987.04607.24","article-title":"Effects of exercise training and deconditioning on platelet aggregation induced by alternating shear stress in men","volume":"25","author":"Wang","year":"2005","journal-title":"Arterioscl Thromb Vascul Biol"},{"key":"10.1016\/j.atherosclerosis.2008.12.010_bib8","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.2337\/diabetes.53.8.2117","article-title":"Surface expression of collagen receptor Fc receptor-gamma\/glycoprotein VI is enhanced on platelets in type 2 diabetes and mediates release of CD40 ligand and activation of endothelial cells","volume":"53","author":"Cabeza","year":"2004","journal-title":"Diabetes"},{"key":"10.1016\/j.atherosclerosis.2008.12.010_bib9","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.abb.2004.09.034","article-title":"Store-operated Ca2+ entry and tyrosine kinase pp60(src) hyperactivity are modulated by hyperglycemia in platelets from patients with non insulin-dependent diabetes mellitus","volume":"432","author":"Saavedra","year":"2004","journal-title":"Arch Biochem Biophys"},{"key":"10.1016\/j.atherosclerosis.2008.12.010_bib10","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.thromres.2003.12.016","article-title":"Reduced sensitivity of platelets from type 2 diabetic patients to acetylsalicyclic acid (aspirin)\u2014its relation to metabolic control","volume":"113","author":"Watala","year":"2004","journal-title":"Thromb Res"},{"key":"10.1016\/j.atherosclerosis.2008.12.010_bib11","doi-asserted-by":"crossref","first-page":"4486","DOI":"10.1182\/blood.V99.12.4486","article-title":"Endothelial von Willebrand factor recruits platelets to atherosclerosis-prone sites in response to hypercholesterolemia","volume":"99","author":"Theilmeier","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.atherosclerosis.2008.12.010_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0168-8227(00)00160-1","article-title":"The role of platelets in diabetes-related vascular complications","volume":"50","author":"Sobol","year":"2000","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.atherosclerosis.2008.12.010_bib13","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.2337\/diab.44.11.1318","article-title":"Impaired insulin-induced platelet antiaggregating effect in obesity and in obese niddm patients","volume":"44","author":"Trovati","year":"1995","journal-title":"Diabetes"},{"key":"10.1016\/j.atherosclerosis.2008.12.010_bib14","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/236450a0","article-title":"Smoking, platelets and thrombosis","volume":"236","author":"Hawkins","year":"1972","journal-title":"Nature"},{"key":"10.1016\/j.atherosclerosis.2008.12.010_bib15","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1046\/j.1538-7836.2003.00212.x","article-title":"Quercetin inhibits collagen-stimulated platelet activation through inhibition of multiple components, of the glycoprotein VI signaling pathway","volume":"1","author":"Hubbard","year":"2003","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.atherosclerosis.2008.12.010_bib16","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1111\/j.1538-7836.2004.01067.x","article-title":"Ingestion of quercetin inhibits platelet aggregation and essential components of the collagen-stimulated platelet activation pathway in humans","volume":"2","author":"Hubbard","year":"2004","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.atherosclerosis.2008.12.010_bib17","doi-asserted-by":"crossref","first-page":"292S","DOI":"10.1093\/ajcn\/81.1.292S","article-title":"Polyphenols and cardiovascular disease: effects on endothelial and platelet function","volume":"81","author":"Vita","year":"2005","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.atherosclerosis.2008.12.010_bib18","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1038\/nrd1198","article-title":"Antiplatelet therapy: in search of the \u2018magic bullet\u2019","volume":"2","author":"Jackson","year":"2003","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.atherosclerosis.2008.12.010_bib19","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1038\/bjp.2008.151","article-title":"Future innovations in anti-platelet therapies","volume":"154","author":"Barrett","year":"2008","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.atherosclerosis.2008.12.010_bib20","doi-asserted-by":"crossref","first-page":"149","DOI":"10.2165\/00129784-200606030-00002","article-title":"The role of oral antiplatelet agents in atherothrombotic disease","volume":"6","author":"Ferguson","year":"2006","journal-title":"Am J Cardiovasc Drugs"},{"key":"10.1016\/j.atherosclerosis.2008.12.010_bib21","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1161\/01.RES.0000264509.36234.51","article-title":"Clinical aspects of platelet inhibitors and thrombus formation","volume":"100","author":"Meadows","year":"2007","journal-title":"Circ Res"},{"key":"10.1016\/j.atherosclerosis.2008.12.010_bib22","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1038\/nm1626","article-title":"Platelet CD36 links hyperlipidemia, oxidant stress and a prothrombotic phenotype","volume":"13","author":"Podrez","year":"2007","journal-title":"Nat Med"},{"key":"10.1016\/j.atherosclerosis.2008.12.010_bib23","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S0092-8674(00)80983-6","article-title":"Initiation of platelet adhesion by arrest onto fibrinogen or translocation on von Willebrand factor","volume":"84","author":"Savage","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.atherosclerosis.2008.12.010_bib24","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0014-5793(97)00926-5","article-title":"Glycoprotein VI is the collagen receptor in platelets which underlies tyrosine phosphorylation of the Fc receptor \u03b3-chain","volume":"413","author":"Gibbins","year":"1997","journal-title":"FEBS Lett"},{"key":"10.1016\/j.atherosclerosis.2008.12.010_bib25","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1093\/emboj\/16.9.2333","article-title":"The Fc receptor \u03b3-chain and the tyrosine kinase Syk are essential for activation of mouse platelets by collagen","volume":"16","author":"Poole","year":"1997","journal-title":"EMBO J"},{"key":"10.1016\/j.atherosclerosis.2008.12.010_bib26","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1172\/JCI6042","article-title":"Protease-activated receptors 1 and 4 mediate activation of human platelets by thrombin","volume":"103","author":"Kahn","year":"1999","journal-title":"J Clin Invest"},{"key":"10.1016\/j.atherosclerosis.2008.12.010_bib27","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1182\/blood-2004-04-1257","article-title":"Integrins: dynamic scaffolds for adhesion and signaling in platelets","volume":"104","author":"Shattil","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.atherosclerosis.2008.12.010_bib28","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1182\/blood.V94.5.1648","article-title":"Glycoprotein Ib-V-IX, a receptor for von Willebrand factor, couples physically and functionally to the Fc receptor gamma-chain, Fyn, and Lyn to activate human platelets","volume":"94","author":"Falati","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.atherosclerosis.2008.12.010_bib29","doi-asserted-by":"crossref","first-page":"2965","DOI":"10.1074\/jbc.M110070200","article-title":"Distinct glycoprotein Ib\/V\/IX and integrin alpha(IIb)beta(3)-dependent calcium signals cooperatively regulate platelet adhesion under flow","volume":"277","author":"Nesbitt","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.atherosclerosis.2008.12.010_bib30","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1146\/annurev.pharmtox.46.120604.141207","article-title":"Regulation of platelet functions by P2 receptors","volume":"46","author":"Gachet","year":"2006","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1016\/j.atherosclerosis.2008.12.010_bib31","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/35051599","article-title":"Identification of the platelet ADP receptor targeted by antithrombotic drugs","volume":"409","author":"Hollopeter","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.atherosclerosis.2008.12.010_bib32","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0163-7258(96)00103-9","article-title":"Platelet prostanoid receptors","volume":"72","author":"Armstrong","year":"1996","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.atherosclerosis.2008.12.010_bib33","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1517\/13543784.10.5.865","article-title":"Inhibitors of platelet signal transduction as anti-aggregatory drugs","volume":"10","author":"Geiger","year":"2001","journal-title":"Exp Opin Invest Drugs"},{"key":"10.1016\/j.atherosclerosis.2008.12.010_bib34","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/S0140-6736(87)91481-4","article-title":"Endogenous nitric-oxide inhibits human-platelet adhesion to vascular endothelium","volume":"2","author":"Radomski","year":"1987","journal-title":"Lancet"},{"key":"10.1016\/j.atherosclerosis.2008.12.010_bib35","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1182\/blood-2005-04-1512","article-title":"Platelet PECAM-1 inhibits thrombus formation in vivo","volume":"107","author":"Falati","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.atherosclerosis.2008.12.010_bib36","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1182\/blood.V97.6.1727","article-title":"PECAM-1 servesas an inhibitory receptor that modulates platelet responses to collagen","volume":"97","author":"Patil","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.atherosclerosis.2008.12.010_bib37","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1136\/bmj.324.7329.71","article-title":"Antithrombotic Trialists\u2019 Collaboration, Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients","volume":"324","year":"2002","journal-title":"Br Med J"},{"key":"10.1016\/j.atherosclerosis.2008.12.010_bib38","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/S0140-6736(96)09457-3","article-title":"CAPRIE Steering Committee, a randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee","volume":"348","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.atherosclerosis.2008.12.010_bib39","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1056\/NEJM198308183090703","article-title":"Protective effects of aspirin against acute myocardial-infarction and death in men with unstable angina\u2014results of a veterans-administration-Cooperative Study","volume":"309","author":"Lewis","year":"1983","journal-title":"N Engl J Med"},{"key":"10.1016\/j.atherosclerosis.2008.12.010_bib40","first-page":"206","article-title":"Targeted inhibition of the serotonin 5-HT2A receptor improves coronary patency in an in vivo model of recurrent thrombosis","volume":"116","author":"Przyklenk","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2008.12.010_bib41","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1161\/01.CIR.100.4.437","article-title":"Platelet glycoprotein IIb\/IIIa antagonists. What are the relevant issues concerning their pharmacology and clinical use?","volume":"100","author":"Scarborough","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2008.12.010_bib42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0002-9343(02)01145-2","article-title":"Multi-year follow-up of abciximab therapy in three randomized, placebo-controlled trials of percutaneous coronary revascularization","volume":"113","author":"Topol","year":"2002","journal-title":"Am J Med"},{"key":"10.1016\/j.atherosclerosis.2008.12.010_bib43","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/S0002-9149(01)01631-9","article-title":"Profile and prevalence of aspirin resistance in patients with cardiovascular disease","volume":"88","author":"Gum","year":"2001","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.atherosclerosis.2008.12.010_bib44","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1002\/ccd.20165","article-title":"Clopidogrel resistance","volume":"63","author":"Heptinstall","year":"2004","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.atherosclerosis.2008.12.010_bib45","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1172\/JCI115468","article-title":"Von Willebrand-factor binding to platelet GPIb initiates signals for platelet activation","volume":"88","author":"Kroll","year":"1991","journal-title":"J Clin Invest"},{"key":"10.1016\/j.atherosclerosis.2008.12.010_bib46","doi-asserted-by":"crossref","first-page":"29019","DOI":"10.1074\/jbc.274.41.29019","article-title":"The platelet collagen receptor glycoprotein VI is a member of the immunoglobulin superfamily closely related to the FcalphaR and the natural killer receptors","volume":"274","author":"Clemetson","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1016\/j.atherosclerosis.2008.12.010_bib47","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/84667","article-title":"Deficiency or inhibition of Gas6 causes platelet dysfunction and protects mice against thrombosis","volume":"7","author":"Angelillo-Scherrer","year":"2001","journal-title":"Nat Med"},{"key":"10.1016\/j.atherosclerosis.2008.12.010_bib48","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/nm0302-247","article-title":"CD40L stabilizes arterial thrombi by a beta(3) integrin-dependent mechanism","volume":"8","author":"Andre","year":"2002","journal-title":"Nat Med"},{"key":"10.1016\/j.atherosclerosis.2008.12.010_bib49","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1080\/mic.10.3-4.335.350","article-title":"Platelet chemokines and chemokine receptors: linking hemostasis, inflammation, and host defense","volume":"10","author":"Gear","year":"2003","journal-title":"Microcirculation"},{"key":"10.1016\/j.atherosclerosis.2008.12.010_bib50","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1073\/pnas.0606344104","article-title":"Regulated surface expression and shedding support a dual role for semaphorin 4D in platelet responses to vascular injury","volume":"104","author":"Zhu","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.atherosclerosis.2008.12.010_bib51","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1182\/blood-2003-11-3979","article-title":"Tachykinins regulate the function of platelets","volume":"104","author":"Graham","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.atherosclerosis.2008.12.010_bib52","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1182\/blood-2007-07-103424","article-title":"Peripheral tachykinins and the neurokinin receptor NK1 are required for platelet thrombus formation","volume":"111","author":"Jones","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.atherosclerosis.2008.12.010_bib53","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1182\/blood-2004-05-1882","article-title":"Platelets feel your pain","volume":"104","author":"Flaumenhaft","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.atherosclerosis.2008.12.010_bib54","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1124\/pr.54.2.285","article-title":"The tachykinin peptide family","volume":"54","author":"Severini","year":"2002","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.atherosclerosis.2008.12.010_bib55","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1113\/jphysiol.2002.018846","article-title":"Neurokinin B induces oedema formation in mouse lung via tachykinin receptor-independent mechanisms","volume":"543","author":"Grant","year":"2002","journal-title":"J Physiol"},{"key":"10.1016\/j.atherosclerosis.2008.12.010_bib56","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1054\/npep.2000.0825","article-title":"Peripheral actions of tachykinins","volume":"34","author":"Lecci","year":"2000","journal-title":"Neuropeptides"},{"key":"10.1016\/j.atherosclerosis.2008.12.010_bib57","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0014-2999(01)01301-2","article-title":"Peripheral tachykinin receptors as targets for new drugs","volume":"429","author":"Patacchini","year":"2001","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.atherosclerosis.2008.12.010_bib58","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/80826","article-title":"Hemokinin is a hematopoietic-specific tachykinin that regulates B lymphopoiesis","volume":"1","author":"Zhang","year":"2000","journal-title":"Nat Immunol"},{"key":"10.1016\/j.atherosclerosis.2008.12.010_bib59","doi-asserted-by":"crossref","first-page":"6245","DOI":"10.1073\/pnas.0931458100","article-title":"Characterisation of the endokinins: human tachykinins with cardiovascular activity","volume":"100","author":"Page","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.atherosclerosis.2008.12.010_bib60","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/1357-2725(96)00017-9","article-title":"Tachykinins: receptor to effector","volume":"28","author":"Khawaja","year":"1996","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1016\/j.atherosclerosis.2008.12.010_bib61","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1111\/j.1476-5381.1981.tb10461.x","article-title":"Shape changes induced by biologically-active peptides and nerve growth-factor in blood-platelets of rabbits","volume":"74","author":"Gudat","year":"1981","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.atherosclerosis.2008.12.010_bib62","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/0014-5793(92)80935-A","article-title":"The Nk1 receptor is involved in the neurokinin-induced shape change of rabbit platelets","volume":"312","author":"Savi","year":"1992","journal-title":"FEBS Lett"},{"key":"10.1016\/j.atherosclerosis.2008.12.010_bib63","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/0162-3109(96)00035-5","article-title":"The effect of bradykinin and substance P on the arachidonate cascade of platelets","volume":"33","author":"Gecse","year":"1996","journal-title":"Immunopharmacology"},{"key":"10.1016\/j.atherosclerosis.2008.12.010_bib64","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1159\/000024057","article-title":"Effects of inflammatory neuropeptides on the arachidonate cascade of platelets","volume":"118","author":"Gecse","year":"1999","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.atherosclerosis.2008.12.010_bib65","first-page":"89","article-title":"The effect of substance P on the arachidonate cascade of rat platelets","volume":"85","author":"Kis","year":"1997","journal-title":"Acta Physiol Hung"},{"key":"10.1016\/j.atherosclerosis.2008.12.010_bib66","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1038\/35015579","article-title":"Excessive placental secretion of neurokinin B during the third trimester causes pre-eclampsia","volume":"405","author":"Page","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.atherosclerosis.2008.12.010_bib67","doi-asserted-by":"crossref","first-page":"225","DOI":"10.4049\/jimmunol.151.1.225","article-title":"Substance-P modulates antigen-induced, Ifn-gamma production in murine schistosomiasis-Mansoni","volume":"151","author":"Blum","year":"1993","journal-title":"J Immunol"},{"key":"10.1016\/j.atherosclerosis.2008.12.010_bib68","doi-asserted-by":"crossref","first-page":"5654","DOI":"10.4049\/jimmunol.159.11.5654","article-title":"Human monocytes and macrophages express substance P and neurokinin-1 receptor","volume":"159","author":"Ho","year":"1997","journal-title":"J Immunol"},{"key":"10.1016\/j.atherosclerosis.2008.12.010_bib69","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/S0165-5728(98)00025-3","article-title":"Human lymphocytes express substance P and its receptor","volume":"86","author":"Lai","year":"1998","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.atherosclerosis.2008.12.010_bib70","doi-asserted-by":"crossref","first-page":"2630","DOI":"10.1073\/pnas.95.5.2630","article-title":"Hypoalgesia in mice with a targeted deletion of the tachykinin 1 gene","volume":"95","author":"Zimmer","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.atherosclerosis.2008.12.010_bib71","first-page":"187","article-title":"In vivo models of platelet function and thrombosis: study of real-time thrombus formation","volume":"272","author":"Falati","year":"2004","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.atherosclerosis.2008.12.010_bib72","first-page":"613","article-title":"Neurokinin 1 receptor antagonists\u2014current prospects","volume":"10","author":"Alvaro","year":"2007","journal-title":"Curr Opin Drug Disc Dev"},{"key":"10.1016\/j.atherosclerosis.2008.12.010_bib73","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1517\/14728214.9.1.9","article-title":"Potential therapeutic targets for neurokinin-1 receptor antagonists","volume":"9","author":"Duffy","year":"2004","journal-title":"Expert Opin Emerg Drugs"},{"key":"10.1016\/j.atherosclerosis.2008.12.010_bib74","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1517\/14656566.4.12.2279","article-title":"Aprepitant\u2014a novel NK1-receptor antagonist","volume":"4","author":"Patel","year":"2003","journal-title":"Exp Opin Pharm"}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915008008988?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915008008988?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,22]],"date-time":"2023-05-22T23:48:48Z","timestamp":1684799328000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915008008988"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,9]]},"references-count":74,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,9]]}},"alternative-id":["S0021915008008988"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2008.12.010","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2009,9]]}}}